Errata and Technical Corrections – CPT 2023 

Errata and Technical Corrections – CPT 2023 

Revise guideline by replacing the term “immediate” with the term “intermediate” in the Evaluation and Management Nursing Facility Services subsection for CPT 2023. 

1. Surgery Digestive System Intestines (except rectum) other procedures 

Original:  

44705 Preparation of fecal microbiota for instillation, including assessment of donor specimen. 

Revision:  

Do not report 44705 in conjunction with 74283, 0780T. 

For fecal instillation by oro-nasogastric tube or enema, use 44799. 

For instillation of fecal microbiota suspension via rectal enema, use 0780T for CPT 2023. 

Note: Revise parenthetical note following code 44705 by removing the term “or enema” from the Surgery Other Procedures subsection. 

2. Surgery Urinary System Bladder Transurethral Surgery Urethra and Bladder 

Original: 

52281 Cystourethroscopy, with calibration and/or dilation of urethral stricture or stenosis, with or without meatotomy, with or without injection procedure for cystography, male or female 

Revision: 

To report cystourethroscopy with urethral therapeutic drug delivery, use 0499T in CPT 2023 changes. 

Note: Reinstate code 0499T and the related parenthetical note following code 52281 in the Surgery Urethra and Bladder subsection. 

3. Medicine Cardiovascular Noninvasive Physiologic Studies and Procedures for CPT 2023 

Original:  

Bioimpedance-derived physiologic cardiovascular analysis 

Revision: 

For bioelectrical impedance analysis whole body composition, use 0358T.  

For left ventricular filling pressure indirect measurement by computerized calibration of the arterial waveform response to Valsalva, use 93799. 

Original: 

93745 93702 Bioimpedance spectroscopy (BIS), extracellular fluid analysis for lymphedema assessment(s) 

Revision: 

For bioelectrical impedance analysis whole body composition, use 0358T in CPT 2023 codes changes.

For bioimpedance-derived physiological cardiovascular analysis, use 93701 

Note: Correct duplication error following code 93701 in the Medicine Noninvasive Physiologic Studies and Procedures subsection by replacing code 93745 with code 93702. 

4. Pathology and Laboratory Genomic Sequencing Procedures and Other Molecular Multianalyte Assays 

Genomic sequencing procedures (GSPs) and other molecular multianalyte assays GSPs are DNA or RNA sequence analysis methods that simultaneously assay multiple genes or genetic regions relevant to a clinical situation. They may target specific combinations of genes or genetic material or assay the exome or genome. 

When a GSP assay includes gene(s) that is listed in more than one code descriptor, the code for the most specific test for the primary disorder sought should be reported, rather than reporting multiple codes for the same gene(s). When all of the components of the descriptor are not performed, use individual Tier 1 codes, Tier 2 codes, or 81479 (Unlisted molecular pathology procedure). 

For targeted genomic sequence DNA analysis or DNA and RNA analysis using a single combined method, report 81445, 81450, or 81455. For targeted genomic sequence RNA analysis when performed using a separate method, report 81449, 81451, 81456. For targeted genomic sequence DNA analysis and RNA analysis performed separately rather than via a combined method, report 81445, 81450, or 81455 for the DNA analysis and report 81449, 81451, or 81456 for the RNA analysis. 

For cytogenomic [genome-wide] analysis for constitutional chromosomal abnormalities, see 81228, 81229, 81349, 81405, 81406) 

Note: Revise parenthetical note by adding code 81349 in the Pathology and Laboratory Genomic Sequencing Procedures and Other Molecular Multianalyte Assays subsection. 

5. Appendix Q Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID 19]) Vaccine 

Original: 

NDC 10/NDC 11 Labeler Product ID (Vial) – ►80777-279-05 80777-0279- 057◄ 

Revised: Remove the number “7” in the NDC 10/NDC 11 Labeler Product ID (Vial) section for code 91311 in Appendix Q. 

6. Canaloplasty – 69631, 69635 

Revise index by removing the letter “o” from the term “Canaloplasty” to reflect the term “Canalplasty” for CPT 2023. 

7. Short Descriptor Data File 

Original: 

81455 TGSAP SO/HL 51/<DNA/DNA&RNA 

Revised: 

Revise the short descriptor data file by removing the “<” symbol and adding a “>” symbol for code 81455 in CPT 2023 changes. 

8. Short Descriptor Data File 

Original:  

81456 TGSAP SO/HL 51/< RNA ALYS 

Revised: 

Revise the short descriptor data file by removing the “<” symbol and adding a “>” symbol for code 81456. 

9. Medium Descriptor Data File 

Original:  

81455 TGSAP SO/HEMATOLYMPHOID NEO/DO 51/<DNA/DNA&RNA 

Revised: 

Revise the medium descriptor data file by removing the “<” symbol and adding a “>” symbol for code 81455. 

10. Medium Descriptor Data File 

Original: 

81456 TGSAP SO/HEMATOLYMPHOID NEO/DO 51/<RNA ANALYSIS 

Revised: 

Revise the medium descriptor data file by removing the “<” symbol and adding a “>” symbol for code 81456. 

11. Appendix T 

Add codes 96121, 96156, 96158, 96159, 96164, 96165, 96167, 96168, 96170, and 96171 to the CPT® codes that may be used for synchronous real-time interactive audio-only telemedicine services. 

12. Appendix P 

Add codes 96121, 96156, 96158, 96159, 96164, 96165, 96167, 96168, 96170, and 96171 to the CPT® codes that may be used for synchronous telemedicine services. 

To stay updated on CPT 2023 changes, check out this space! 

Spread the love
Facebook
Twitter
LinkedIn
Pinterest

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top